Latest News and Press Releases

NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Blueprint Medicines Corporation (“Blueprint” or the “Company”) (NASDAQ: BPMC). Such...

NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 21, 2022, please note the lead plaintiff deadline should be June 21st instead of June 20th, 2022. The...

NEW YORK, June 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Verrica Pharmaceuticals, Inc. (“”Verrica or the “Company”) (NASDAQ: VRCA).   Such...

NEW YORK, June 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Apyx Medical Corporation (“Apyx” or the “Company”) (NASDAQ: APYX). Such investors are...

紐約, June 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP 宣佈已對 Credit Suisse Group AG（「Credit Suisse」或「公司」) (NYSE: CS) 及其部分高層人員提出集體訴訟。  該集體訴訟已在美國紐約東區地方法院提出，案卷編號 22-cv-02477，其代表除被告外於 2021 年 3 月 19 日至 2022...

NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Credit Suisse Group AG (“Credit Suisse” or the “Company”) (NYSE: CS) and...

NEW YORK, June 05, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of First High-School Education Group Co., Ltd. (“”or the “Company”) (NYSE: FHS).   Such...

NEW YORK, June 05, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SoftBank Group Corp. (“”or the “Company”) (OTCMKTS: SFTBY).   Such investors are advised...

NEW YORK, June 05, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dentsply Sirona Inc. (“Dentsply Sirona” or the “Company”) (NASDAQ: XRAY). Such investors...

NEW YORK, June 05, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abbott Laboratories (“Abbott” or the “Company”) (NYSE: ABT).   Such investors are advised...